Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. TTD
2. NET
3. ABNB
4. TEAM
5. DV
6. FROG
7. TWLO
8. CART
9. SPY
10. U

Go back to Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
(NASDAQ: PRME) Delayed: 3.08 +0.13 (4.41%)
Previous Close $2.95    52 Week High $21.72 
Open $3.00    52 Week Low $18.36 
Day High $3.12    P/E N/A 
Day Low $2.97    EPS $0.00 
Volume 1,976,333